Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001701247-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 27, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
120,000
Total Value
$1,503,224.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | Mar 25, 2026 | Exercise/Conversion | 40,000 | $2.48 | $99,200.00 | 65,000 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Mar 25, 2026 | Sale | 40,000 | $35.10 | $1,404,024.00 | 25,000 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Stock Option (right to buy) | Derivative | Mar 25, 2026 | Exercise/Conversion | 40,000 | $0.00 | $0.00 | 136,268 | Direct | โ | View Details |